Former Ambassador Nancy Brinker, founder of Susan G. Komen, talks about the stigma that used to surround breast cancer and how she brought awareness to the disease.
Transcript
When you started the Susan G. Komen Foundation, there was a lot of stigma surrounding the subject of breast cancer. How did you bring the conversation about breast cancer into the open?
Well we really brought it out into the open because it was there, it was growing. People just didn't have the place to talk about it or share their feelings or share their insights or survival or their treatment—or their lack of survival. It was really waiting to happen. Because I had lost my only sister to the disease in 1980 and she asked me, I promised her that I would help cure breast cancer.
So, it's been a long ride, a long time, it's been almost 40 years of my life—she was diagnosed in 1978—and I realize that we had to do something, and it was going to require a movement. It wasn't just going to be a one [time] fundraiser, it was a movement. And of course, this pre-dated computers and cellphones and fax machines and everything else. We really only had telephones and each other to work with.
So, we named it Susan G. Komen in her honor—her memory—and set about working for many many years. We've managed to bring up the awareness, the sharing, and we've created a large community—a worldwide community—focused on breast cancer.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Specialty Pharmacists at the Forefront: Elevating Care for Rare Diseases
May 1st 2024In the US, a disease is considered rare when it affects fewer than 200,000 persons, or 1 in every 1500 individuals, with an estimated total of 25 to 30 million Americans overall living with a rare disease at any given time.
Read More
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More